CCR9 and myelodysplastic syndrome: Together with the upregulation of several pro-inflammatory genes in MDS BM (e.g., TNF, IFNL1, CCR9) (Fig. 1E), these findings suggest the presence of a phenotypically preserved but functionally altered T cell population contributing to the inflammatory milieu in MDS.